Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | ACTC1 CL E G H | 70 | 143 | OMIM:613424 | Cardiomyopathy, dilated, 1R | | | | 208 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | ACTN2 CL E G H | 88 | 164 | OMIM:612158 | Cardiomyopathy, dilated, 1aa, with or without left ventricular noncompaction | | | | 307 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | ALPK3 CL E G H | 57538 | 17574 | OMIM:618052 | Cardiomyopathy, familial hypertrophic 27 | | | | 89 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | CACNA1S CL E G H | 779 | 1397 | ORPHA:423 | Malignant hyperthermia of anesthesia | | | | 247 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | COA5 CL E G H | 493753 | 33848 | OMIM:616500 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3 | | | | 2 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | DOLK CL E G H | 22845 | 23406 | ORPHA:91131 | DK1-CDG | | | | 55 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | DSP CL E G H | 1832 | 3052 | OMIM:605676 | Cardiomyopathy, dilated, with woolly hair and keratoderma | | | | 747 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | GYG1 CL E G H | 2992 | 4699 | ORPHA:263297 | Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency | | | | 18 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | GYG1 CL E G H | 2992 | 4699 | OMIM:613507 | Glycogen storage disease XV | | | | 18 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | LMOD2 CL E G H | 442721 | 6648 | OMIM:619897 | | | | | | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | PNPLA2 CL E G H | 57104 | 30802 | ORPHA:565612 | Triglyceride deposit cardiomyovasculopathy | HP:0040281 - Very frequent | | | 65 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | RPL3L CL E G H | 6123 | 10351 | OMIM:619371 | CARDIOMYOPATHY, DILATED, 2D; CMD2D | | | | | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | RYR1 CL E G H | 6261 | 10483 | ORPHA:423 | Malignant hyperthermia of anesthesia | | | | 1200 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | TNNI3 CL E G H | 7137 | 11947 | OMIM:611880 | Cardiomyopathy, dilated, 2A | | | | 180 | | |
HP:0031331 | HP:0031331 | Abnormal cardiomyocyte morphology | 0 | VCL CL E G H | 7414 | 12665 | OMIM:613255 | Cardiomyopathy, familial hypertrophic, 15 | | | | 248 | | |
HP:0031331 | HP:0031335 | Abnormal cardiomyocyte mitochondrial morphology | 1 | CL E G H | | | | | | | | | | |
HP:0031331 | HP:0031334 | Cardiomyocyte inclusion bodies | 1 | CL E G H | | | | | | | | | | |
HP:0031331 | HP:0031332 | Cardiomyocyte degeneration | 1 | CL E G H | | | | | | | | | | |
HP:0031331 | HP:0031339 | Abnormal cadiomyocyte dystrophin staining | 1 | CL E G H | | | | | | | | | | |
HP:0031331 | HP:0031338 | Abnormal cardiomyocyte plakoglobin staining | 1 | CL E G H | | | | | | | | | | |
HP:0031331 | HP:0031337 | Abnormal cardiomyocyte connexin43 staining | 1 | CL E G H | | | | | | | | | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | ACTC1 CL E G H | 70 | 143 | OMIM:613424 | Cardiomyopathy, dilated, 1R | | | | 208 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | ACTN2 CL E G H | 88 | 164 | OMIM:612158 | Cardiomyopathy, dilated, 1aa, with or without left ventricular noncompaction | . | | | 307 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | ALPK3 CL E G H | 57538 | 17574 | OMIM:618052 | Cardiomyopathy, familial hypertrophic 27 | | | | 89 | | |
HP:0031331 | HP:0031320 | Cardiomyocyte mitochondrial proliferation | 1 | CACNA1S CL E G H | 779 | 1397 | ORPHA:423 | Malignant hyperthermia of anesthesia | HP:0040282 - Frequent | | | 247 | | |
HP:0031331 | HP:0031320 | Cardiomyocyte mitochondrial proliferation | 1 | COA5 CL E G H | 493753 | 33848 | OMIM:616500 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3 | | | | 2 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | DOLK CL E G H | 22845 | 23406 | ORPHA:91131 | DK1-CDG | | | | 55 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | DSP CL E G H | 1832 | 3052 | OMIM:605676 | Cardiomyopathy, dilated, with woolly hair and keratoderma | . | | | 747 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | GYG1 CL E G H | 2992 | 4699 | ORPHA:263297 | Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency | HP:0040282 - Frequent | | | 18 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | GYG1 CL E G H | 2992 | 4699 | OMIM:613507 | Glycogen storage disease XV | | | | 18 | | |
HP:0031331 | HP:0031333 | Myocardial sarcomeric disarray | 1 | LMOD2 CL E G H | 442721 | 6648 | OMIM:619897 | | | | | | | |
HP:0031331 | HP:0033997 | Perinuclear cardiomyocyte vacuolization | 1 | RPL3L CL E G H | 6123 | 10351 | OMIM:619371 | CARDIOMYOPATHY, DILATED, 2D; CMD2D | | | | | | |
HP:0031331 | HP:0031320 | Cardiomyocyte mitochondrial proliferation | 1 | RYR1 CL E G H | 6261 | 10483 | ORPHA:423 | Malignant hyperthermia of anesthesia | HP:0040282 - Frequent | | | 1200 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | TNNI3 CL E G H | 7137 | 11947 | OMIM:611880 | Cardiomyopathy, dilated, 2A | | | | 180 | | |
HP:0031331 | HP:0031319 | Cardiomyocyte hypertrophy | 1 | VCL CL E G H | 7414 | 12665 | OMIM:613255 | Cardiomyopathy, familial hypertrophic, 15 | | | | 248 | | |
HP:0031331 | HP:0031336 | Intranuclear cardiomyocyte mitochondria | 2 | CL E G H | | | | | | | | | | |